Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website has updated its contact information and personnel details, including the addition of new contacts and a revision update from v2.13.3 to v2.14.0.
    Difference
    5%
    Check dated 2025-01-12T18:32:43.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2024-12-22T01:43:07.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.4%
    Check dated 2024-12-14T22:48:09.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T16:18:52.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Several key resources related to ovarian cancer and treatment options have been removed, including links to MedlinePlus and NIH, which may impact access to important genetic and disease information.
    Difference
    4%
    Check dated 2024-11-23T04:39:35.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The website has added new recruiting information for a study on ovarian cancer, including multiple principal investigators and their contact details, while removing outdated status and revision information.
    Difference
    9%
    Check dated 2024-11-08T18:23:43.000Z thumbnail image

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.